Health Care/Hospital

Marlabs welcomes Arun Mukunda as Chief Revenue Officer

Accelerates focus on Data, AI, and Digital Product Engineering (DPE) in Lifesciences, Banking, and Healthcare PISCATAWAY, N.J. and BANGALORE, India, April 30, 2024 /PRNewswire/ -- In keeping with its growth plans, the global digital solutions companyMarlabs LLC

2024-04-30 20:49 2167

A Potential First-In-Class Drug: CDE Approved Single-Arm Pivotal Clinical Study of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs

NANJING, China, April 30, 2024 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs") announced that LBL-024, an anti-PD-L1/4-1BB bispecific antibody independently developed by Leads Biolabs with global intellectual property rights has received approval to co...

2024-04-30 20:16 1595

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia

* The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance * Medison, the creator and leader of the multi-regional partnership category, will utilize its unique, unifiedplatform for efficient global commerciali...

2024-04-30 19:00 2892

HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update

* Delivered solid performance to start 2024, with record-breaking first quarter revenue of34.1 billion KRW. Strong sales momentum continued from key products, funding investments in ongoing R&D programs. * Phase 3 VELOS-4 study of tanfanercept in dry eye disease expected to be initiated in th...

2024-04-30 19:00 1443

I-MAB Filed 2023 Annual Report on Form 20-F

ROCKVILLE, Md., April 30, 2024 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that it has filed...

2024-04-30 19:00 2907

BiO-LiFE Herbalmeds Launches The Power of Sleep Campaign To Encourage Malaysians To Sleep Well and Stay Healthy

 Herbalmeds partners with Watsons Malaysia to launch a series of sleep-focused consumer engagement activities KUALA LUMPUR, Malaysia, April 30, 2024 /PRNewswire/ -- With 9 out of 10 Malaysians experiencing some form of sleep disorder[1], getting sufficient and quality sleep has become an elusive...

2024-04-30 16:11 1703

BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report

Three-part report investigates rapid pipeline growth, partnerships, clinical trials, and patient access challenges in cancer treatment LONDON, April 30, 2024 /PRNewswire/ -- BioWorld™ published by  Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, explores the ...

2024-04-30 15:00 1400

Pepsodent enters Malaysia Book of Records for "Most Number of Students Brushing Teeth Simultaneously" with a total of over 6,000 students participating

KUALA LUMPUR, Malaysia, April 30, 2024 /PRNewswire/ -- Pepsodent, in collaboration with the Ministry of Health (MOH) and supported by the Ministry of Education (MOE) driven by Unilever International Malaysia, has achieved a remarkable milestone by setting anew Malaysia Book of Record for the "Mos...

2024-04-30 14:59 1685

111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow

SHANGHAI, April 30, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that it will report its unaudited financial result...

2024-04-30 14:30 1489

Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO)

SAN FRANCISCO and SUZHOU, China, April 30, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune,...

2024-04-30 12:30 2644

WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment

* The Company demonstrated a deep commitment to achieving ESG success in partnership with global clients, creating long-term value for all stakeholders. * The Company made remarkable progress in tackling climate change, achieving a 29% intensity reduction of Scope 1 and Scope 2 greenhouse gas ...

2024-04-30 10:55 1539

Waterdrop Inc. Releases 2023 Annual Report: Sustained Profitability and Impressive Growth in Innovative Businesses

BEIJING, April 29, 2024 /PRNewswire/ -- On April 25, 2024, Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, released its annual report on Form 20-F for the fiscal year ending...

2024-04-30 10:39 3097

Australian Cosmeceutical Brand Neutriderm WINS Best Hair Hairloss Treatment in Hair Awards

SYDNEY, April 30, 2024 /PRNewswire/ -- Neutriderm, a leading Australian Cosmeceutical skin and hair care brand from UAS Pharmaceuticals, has won the Best Hair Loss Treatment for its Hair Enhancing Lotion as part of the Prevention Australia Magazine 2024 Hair Awards. The Hair Enhancing range is th...

2024-04-30 09:36 1417

Chang Gung Memorial Hospital, Linkou, Garners Two Prestigious International Awards for Its Outstanding Achievements

The hospital honored with Hospital of the Year - Taiwan and Smart Hospital Initiative of the Year -Taiwan at the Healthcare Asia Awards TAOYUAN, April 30, 2024 /PRNewswire/ -- The Healthcare Asia Awards, a prestigious international recognition program, honors exceptional healthcare institutions ...

2024-04-30 09:03 2099

Hurom Takes Global Action to Protect Juicer Patents

Protecting Proprietary Technologies and Fostering a Healthy Global Ecosystem SEOUL, South Korea, April 29, 2024 /PRNewswire/ -- Hurom, a pioneer in the development of the slow juicer and a leader in the global market, is stepping up efforts to safeguard patent rights worldwide to protect its prop...

2024-04-29 21:00 1259

Medit launches the revolutionary i900, an intraoral scanning system set to redefine the scanning experience for dental clinics worldwide

* The Medit i900 features cutting-edge technology for smoother, easier scanning, comfortable handling, and improved scan quality SEOUL, South Korea and LONG BEACH, Calif., April 29, 2024 /PRNewswire/ -- Medit (www.medit.com ), a leading provider of dental 3D scanners and ...

2024-04-29 21:00 1503

China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering

HANGZHOU, China, April 29, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ...

2024-04-29 21:00 2231

CARsgen Submitted Responses to FDA Observations

SHANGHAI, April 29, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that responses regarding the status of the Corrective and Preventive...

2024-04-29 20:50 1180

Laekna Releases 2023 ESG Report

SHANGHAI and WARREN, N.J., April 29, 2024 /PRNewswire/ -- Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, released its 2023 Environmental, Social and Governance (ESG) report since its listing on the HKEX onJune 29, 2023.  Laekna means "to cure, to heal", underscor...

2024-04-29 20:30 1284

Henlius Trastuzumab Receives FDA Approval in the United States

SHANGHAI, April 29, 2024 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's business partner, Accord BioPharma Inc. (the U.S. specialty division of Intas Pharmaceuticals, Ltd.), has received approval from the United States Food and Drug Administration (FDA) for ...

2024-04-29 20:18 2573
1 ... 949596979899100 ... 848

Week's Top Stories